Clincosm LogoSign in Get a demo

hepatocellular carcinoma

Showing 1 - 25 of 1,472
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)

Recruiting
  • Hepatocellular Carcinoma
  • [68Ga]Ga-NOTA-RG2 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

Hepatocellular Carcinoma Trial in Tianjin (ultrasonic testing)

Recruiting
  • Hepatocellular Carcinoma
  • ultrasonic testing
  • Tianjin, Tianjin, China
    王芳
Nov 20, 2023

Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 14, 2023

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

Hepatocellular Carcinoma Trial in Shanghai (BC3402 injection, Durvalumab injection)

Not yet recruiting
  • Hepatocellular Carcinoma
  • BC3402 injection
  • Durvalumab injection
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Oct 26, 2023

Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 26, 2023

Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Handgrip strength test
  • +2 more
  • Roma, RM, Italy
    CEMAD
Oct 20, 2023

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Bevacizumab combined with Sintilimab, Transcatheter arterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Bevacizumab combined with Sintilimab
  • Transcatheter arterial chemoembolization
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 14, 2023

Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Lenvatinib, Transarterial Chemoembolization (TACE))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023

Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Sintilimab
  • Transarterial Chemoembolization (TACE)
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023

Hepatocellular Carcinoma Trial in Beijing (1mg NWRD06 administered by electroporation, 4mg NWRD06 administered by

Recruiting
  • Hepatocellular Carcinoma
  • 1mg NWRD06 administered by electroporation
  • +2 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Oct 15, 2023

Hepatocellular Carcinoma Trial in Seoul (Microwave ablation)

Recruiting
  • Hepatocellular Carcinoma
  • Microwave ablation
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 10, 2023

Hepatocellular Carcinoma Trial in United States (AZD5851)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AZD5851
  • Duarte, California
  • +9 more
Oct 12, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Patient-Derived Tumor Organoids
  • Hong Kong, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Oct 12, 2023

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Follow up After TACE by Elastography and Color Doppler.

Not yet recruiting
  • Hepatocellular Carcinoma
  • US
  • (no location specified)
Oct 2, 2023

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guangzhou (bTAE-HAIC, Lenvatinib, Sintilimab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 30, 2023

Cancer, Solid Tumor, Thromboembolism Trial in Tripoli (Palbociclib, Rivaroxaban, SNP)

Recruiting
  • Cancer
  • +12 more
  • Tripoli, North Lebanon, Lebanon
  • +1 more
Oct 5, 2023

End Stage Liver Disease, Acute Liver Failure, Acute-On-Chronic Liver Failure Trial in Riyadh (Donor hepatectomy)

Enrolling by invitation
  • End Stage Liver Disease
  • +3 more
  • Donor hepatectomy
  • Riyadh, Saudi Arabia
    Organ Transplant Center of Excellence, King Faisal Specialist Ho
Sep 28, 2023

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 24, 2023

Cirrhosis, Hepatocellular Carcinoma Trial in Pittsburgh (OASIS DA training, Current DA Tool training)

Not yet recruiting
  • Cirrhosis
  • Hepatocellular Carcinoma
  • OASIS DA training
  • Current DA Tool training
  • Pittsburgh, Pennsylvania
    VA Pittsburgh Healthcare System University Drive Division, Pitts
Sep 27, 2023

Hepatocellular Carcinoma Trial in Jakarta Pusat (Autologous Natural Killer Cell Therapy, Clinimacs Plus)

Recruiting
  • Hepatocellular Carcinoma
  • Autologous Natural Killer Cell Therapy
  • Clinimacs Plus
  • Jakarta Pusat, Jakarta, Indonesia
    Cipto Mangunkusumo General Hospital
Sep 24, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023